Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology

被引:3
|
作者
Draelos, Zoe Diana [1 ]
Draelos, Matthew M. [1 ]
Steele, Fraser [2 ]
Georgiou, Michelle [2 ]
Praestegaard, Morten [3 ]
机构
[1] Dermatol Consulting Serv PLLC, 2444 North Main St, High Point, NC 27262 USA
[2] MC2 Therapeut, Guildford, England
[3] MC2 Therapeut, Horsholm, Denmark
关键词
Drug delivery; PAD technology; Franz diffusion cell; Tape stripping; Betamethasone dipropionate; Psoriasis;
D O I
10.1007/s13555-023-00959-3
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
IntroductionEffective topical drug delivery is the essence of dermatologic treatment. The drug must be applied to the skin surface, be released from the vehicle, enter the stratum corneum, traverse the epidermis, and enter the dermis pharmacologically intact. New advances have improved emulsion-type formulation and drug delivery technology by encapsulating dispersed oil droplets in a robust multimolecular aqueous film of surfactants, oil, and water, enabling a multifold decrease in surfactant concentration compared to conventional creams. In the research reported here, we studied this new concept, termed polyaphron dispersion (PAD) technology, by comparing skin delivery of betamethasone dipropionate from a novel oil-in-water emulsion system of calcipotriene and betamethasone dipropionate (CAL/BDP) cream to that from a traditional topical suspension (CAL/BDP TS) utilizing in vitro and in vivo detection methods.MethodsThe amount of BDP released from the CAL/BDP cream and CAL/BDP TS was evaluated using both in vitro Franz cell analysis and in vivo human tape stripping from ten female human volunteers after a single application of CAL/BDP cream or CAL/BDP TS. For the tape stripping analysis, 20 circular tape strips were taken from forearm application sites at 1, 2, 4, and 8 h after application and analyzed for the amount of BDP in the tape strip using liquid chromatography-mass spectrometry (LC-MS).ResultsThe in vitro Franz cell analysis demonstrated that the cumulative amount of BDP that diffused through the epidermis was statistically significantly greater for the CAL/BDP cream compared to the CAL/BDP TS at all time points. In addition, consistently higher amounts of BDP were recovered following CAL/BDP cream application than following CAL/BDP TS application at 1, 2, 4, and 8 h following application utilizing the in vivo tape stripping technique.ConclusionThe novel PAD technology-based cream formulation delivered more BDP into the upper stratum corneum and lower epidermis than a traditional topical suspension.
引用
收藏
页码:1763 / 1771
页数:9
相关论文
共 50 条
  • [1] Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology
    Zoe Diana Draelos
    Matthew M. Draelos
    Fraser Steele
    Michelle Georgiou
    Morten Praestegaard
    Dermatology and Therapy, 2023, 13 : 1763 - 1771
  • [2] Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil
    Mohd Hanif Zulfakar
    Nassima Abdelouahab
    Charles M. Heard
    Inflammation Research, 2010, 59 : 23 - 30
  • [3] Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil
    Zulfakar, Mohd Hanif
    Abdelouahab, Nassima
    Heard, Charles M.
    INFLAMMATION RESEARCH, 2010, 59 (01) : 23 - 30
  • [4] Evaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug-drug interaction for transdermal drug delivery in miniature pig
    Yu, Biao
    Ma, Pengcheng
    Yuan, Linwen
    Chen, Dingding
    Yang, Jin
    XENOBIOTICA, 2015, 45 (05) : 380 - 384
  • [5] Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study
    Gonzalez-Paredes, Ana
    Manconi, Maria
    Caddeo, Carla
    Ramos-Cormenzana, Alberto
    Monteoliva-Sanchez, Mercedes
    Fadda, Anna Maria
    JOURNAL OF LIPOSOME RESEARCH, 2010, 20 (04) : 269 - 276
  • [6] Enhanced transdermal drug delivery of zaltoprofen using a novel formulation
    Baek, Jong-Suep
    Lim, Ji-Ho
    Kang, Jong-Seong
    Shin, Sang-Chul
    Jung, Sang-Hun
    Cho, Cheong-Weon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 453 (02) : 358 - 362
  • [7] DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis
    Yamauchi, Paul
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (02) : 85 - 91
  • [8] Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients
    Marianne Lind
    Kim Troensegaard Nielsen
    Line Hollesen Schefe
    Kasper Nørremark
    André Huss Eriksson
    Hanne Norsgaard
    Brian Thoning Pedersen
    Karsten Petersson
    Dermatology and Therapy, 2016, 6 : 413 - 425
  • [9] Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients
    Lind, Marianne
    Nielsen, Kim Troensegaard
    Schefe, Line Hollesen
    Norremark, Kasper
    Eriksson, Andre Huss
    Norsgaard, Hanne
    Pedersen, Brian Thoning
    Petersson, Karsten
    DERMATOLOGY AND THERAPY, 2016, 6 (03) : 413 - 425
  • [10] Nanocarriers: A Novel Approach for Enhanced Drug Delivery through Skin
    Rode, Anuja
    Sharma, Sanjay
    Mishra, Dinesh K.
    ASIAN JOURNAL OF PHARMACEUTICS, 2018, 12 (01) : S13 - S20